Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: The University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience
Pf. Nguyen-tan et al., Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: The University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience, INT J RAD O, 50(5), 2001, pp. 1172-1180
Citations number
46
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Purpose: To review the UCSF-SUH experience in the treatment of advanced T3-
4 laryngeal carcinoma and to evaluate the different factors affecting locor
egional control and survival.
Methods and Materials: We reviewed the records of 223 patients treated for
T3-4 squamous cell carcinoma of the larynx between October 1, 1957, and Dec
ember 1, 1999. There were 187 men and 36 women, with a median age of 60 yea
rs (range, 28-85 years). The primary site was glottic in 122 and supraglott
ic in 101 patients. We retrospectively staged the patients according to the
1997 AJCC staging system. One hundred and twenty-seven patients had T3 les
ions, and 96 had T4 lesions; 132 had N0, 29 had N1, 45 had N2, and 17 had N
3 disease. The overall stage was III in 93 and IV in 130 patients. Seventy-
nine patients had cartilage involvement, and 144 did not. Surgery was the p
rimary treatment modality in 161 patients, of which 134 had postoperative r
adiotherapy (RT), 11 had preoperative RT, 7 had surgery followed by RT and
chemotherapy (CT), and 9 had surgery alone. Forty-one patients had RT alone
, and 21 had CT with RT. Locoregional control (I,RC) and overall survival (
OS) were estimated using the Kaplan-Meier method. Log-rank statistics were
employed to identify significant prognostic factors for OS and LRC.
Results: The median follow-up was 41 months (range, 2-367 months) for all p
atients and 78 months (range, 6-332 months) for alive patients. The LRC rat
e was 69% at 5 years and 68% at 10 years. Eighty-four patients relapsed, of
which 53 were locoregional failures. Significant prognostic factors for LR
C on univariate analysis were primary site, N stage, overall stage, the low
est hemoglobin (Hgb) level during RT, and treatment modality. Favorable pro
gnostic factors for LRC on multivariate analysis were lower N stage and pri
mary surgery. The overall survival rate was 48% at 5 years and 34% at 10 ye
ars. Significant prognostic Factors for OS on univariate analysis were: pri
mary site, age, overall stage, T stage, N stage, lowest Hgb level during RT
, and treatment modality. Favorable prognostic factors for OS on multivaria
te analysis were lower N stage and higher Hgb level during RT.
Conclusion: Lower N-stage was a favorable prognostic factor for LRC and OS.
Hgh levels greater than or equal to 12.5 g/dL, during RT was a favorable p
rognostic factor for OS. Surgery was a favorable prognostic factor for LRC
but did not impact on OS. Correcting the Hbg level before and during treatm
ent should be investigated in future clinical trials as a way of improving
therapeutic outcome in patients with advanced laryngeal carcinomas. (C) 200
1 Elsevier Science Inc.